Your browser doesn't support javascript.
loading
[Risk factors of pancreatitis after percutaneous transhepatic biliary drainage in patients with pancreatic cancer and obstructive jaundice].
Li, M; Wang, H S; Wang, C L; Zhang, L; Yang, X L; Xu, Y; Gao, W; Guo, Z; Yu, H P.
Afiliación
  • Li M; Tianjin Medical University Cancer Institute and Hospital, National Clinical Reserch Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300000, China The Affiliated Hospital of Hebei University, Experimental Center of He
  • Wang HS; The Affiliated Hospital of Hebei University, Experimental Center of Hebei University Hospital, Baoding 071000, China.
  • Wang CL; Tianjin Medical University Cancer Institute and Hospital, National Clinical Reserch Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300000, China.
  • Zhang L; Tianjin Medical University Cancer Institute and Hospital, National Clinical Reserch Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300000, China.
  • Yang XL; Tianjin Medical University Cancer Institute and Hospital, National Clinical Reserch Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300000, China.
  • Xu Y; Tianjin Medical University Cancer Institute and Hospital, National Clinical Reserch Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300000, China.
  • Gao W; Tianjin Medical University Cancer Institute and Hospital, National Clinical Reserch Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300000, China.
  • Guo Z; Tianjin Medical University Cancer Institute and Hospital, National Clinical Reserch Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300000, China.
  • Yu HP; Tianjin Medical University Cancer Institute and Hospital, National Clinical Reserch Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300000, China.
Zhonghua Nei Ke Za Zhi ; 61(1): 82-85, 2022 Jan 01.
Article en Zh | MEDLINE | ID: mdl-34979775
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Pancreatitis / Ictericia Obstructiva Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: Zh Revista: Zhonghua Nei Ke Za Zhi Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Pancreatitis / Ictericia Obstructiva Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: Zh Revista: Zhonghua Nei Ke Za Zhi Año: 2022 Tipo del documento: Article